top of page
The Bidirectional Pharma Partnership Model: How MENA Players Access Western Innovation
MENA pharma companies are actively seeking Western innovation, in-licensing, co-development, and biotech access. Discover the bidirectional partnership model that creates value for both sides. | Nexus Pharmalink
4 min read
Why 70% of Pharma Expansions Into MENA Fail And How to Avoid It
70% of pharma expansions into MENA fail. Discover the 4 critical mistakes and the Nexus approach to securing your market entry. Expert guide by Sara Abbad.
2 min read
bottom of page